Bill Text: NY S00649 | 2021-2022 | General Assembly | Amended
Bill Title: Relates to medication assisted treatment for substance abuse disorders; prohibits prior authorization.
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: (Introduced - Dead) 2021-06-03 - SUBSTITUTED BY A2030 [S00649 Detail]
Download: New_York-2021-S00649-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 649--A 2021-2022 Regular Sessions IN SENATE (Prefiled) January 6, 2021 ___________ Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 2 of section 365-a of the social services law 2 is amended by adding a new paragraph (gg) to read as follows: 3 (gg) all buprenorphine products, methadone or long acting injectable 4 naltrexone for detoxification or maintenance treatment of a substance 5 use disorder prescribed according to generally accepted national profes- 6 sional guidelines for the treatment of a substance use disorder. Such 7 medication assisted treatment shall not be subject to any prior authori- 8 zation mandate. 9 § 2. Subdivision 26-b of section 364-j of the social services law, as 10 added by section 4 of part B of chapter 69 of the laws of 2016, is 11 amended to read as follows: 12 26-b. Managed care providers shall not require prior authorization for 13 [an initial or renewal prescription for buprenorphine or injectable14naltrexone for detoxification or maintenance treatment of opioid15addiction unless the prescription is for a non-preferred or non-formu-16lary form of the drug or as otherwise required by section 1927(k)(6) of17the Social Security Act] any buprenorphine products, methadone or long 18 acting injectable naltrexone for detoxification or maintenance treatment 19 of a substance use disorder prescribed according to generally accepted 20 national professional guidelines for the treatment of a substance use 21 disorder. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD00371-03-1S. 649--A 2 1 § 3. Subdivision 10 of section 273 of the public health law, as 2 amended by section 7 of part GG of chapter 56 of the laws of 2020, is 3 amended to read as follows: 4 10. Prior authorization shall not be required for [an initial or5renewal prescription for buprenorphine or injectable naltrexone for6detoxification or maintenance treatment of opioid addiction unless the7prescription is for a non-preferred or non-formulary form of such drug8as otherwise required by section 1927(k)(6) of the Social Security Act.9Further, prior authorization shall not be required for] any buprenor- 10 phine products, methadone, [when used for opioid use disorder and admin-11istered or dispensed in an opioid treatment program] or long acting 12 injectable naltrexone for detoxification or maintenance treatment of a 13 substance use disorder prescribed according to generally accepted 14 national professional guidelines for the treatment of a substance use 15 disorder. 16 § 4. This act shall take effect on the ninetieth day after it shall 17 have become a law; provided, however, that the amendments to subdivision 18 26-b of section 364-j of the social services law made by section two of 19 this act shall not affect the repeal of such section, and shall be 20 deemed repealed therewith.